Back | Next |
home / stock / pali / pali message board
Subject | By | Source | When |
---|---|---|---|
15 | peterus | investorshub | 03/31/2023 7:25:50 PM |
5 or 50? | IOUBLOKE1 | investorshub | 03/31/2023 7:25:09 PM |
3.58s back 3.40s shortie is stronge | peterus | investorshub | 03/31/2023 6:28:31 PM |
going to fly ..... watch out shorts need | peterus | investorshub | 03/31/2023 5:43:31 PM |
BOUGHT AT 2.23 SOLD AT 3.42 | WHIP THE HORSE | investorshub | 03/31/2023 4:30:04 PM |
cash on hand mid 2024 phase2 data Q2 | peterus | investorshub | 03/31/2023 3:31:45 PM |
bought in 3.10s could see a nice runner | peterus | investorshub | 03/31/2023 3:29:24 PM |
Here we go! | Jess070283 | investorshub | 03/31/2023 3:06:52 PM |
it's now 3.46 in the premarket . Once | podacs | investorshub | 03/31/2023 12:06:07 PM |
$PALI ------- $2.99 after hours. Tomorrow | WHIP THE HORSE | investorshub | 03/30/2023 8:41:35 PM |
better get some before the rest of the | podacs | investorshub | 03/30/2023 7:50:30 PM |
PALI $2.62 A BEAST IS BORN | WHIP THE HORSE | investorshub | 03/30/2023 6:36:58 PM |
PALI $.251 NOW, UP 48% | WHIP THE HORSE | investorshub | 03/30/2023 6:05:54 PM |
$PALI moving nicely, target $50 by MAXIM GROUP | WHIP THE HORSE | investorshub | 03/30/2023 6:04:46 PM |
Maxim Group $50 price target. This one best | podacs | investorshub | 03/30/2023 3:25:07 PM |
$PALI target announced to $50 by Maxim Group | WHIP THE HORSE | investorshub | 03/30/2023 3:24:44 PM |
$PALI a monster in the making.!!!!! | WHIP THE HORSE | investorshub | 03/30/2023 2:37:59 PM |
PALI HI https://www.benzinga.com/news/23/03/31583007/maxim-group-upgrades-palisade-bio-to-buy-announ | TheFinalCD | investorshub | 03/30/2023 1:51:55 PM |
Can you tell me what you think about | traderbbc1 | investorshub | 02/07/2023 1:23:11 AM |
znewcar1: $PALI 29% v9,587M c2.90 f2,018M H3.55 ML2.11 RL2.22 | znewcar1 | investorshangout | 01/31/2023 11:02:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...